Dextrorphan prodrugs and processes for making and using them
Abstract:
The presently described technology provides compositions of one or more of oxoacids, polyethylene glycols, and/or vitamin compounds chemically conjugated to dextrorphan, (+)-17-methylmorphinan-3-ol), to form novel prodrugs and compositions of dextrorphan.
Information query
Patent Agency Ranking
0/0